Brainstorm Cell Therapeutics (BCLI) Long-Term Investments (2010 - 2015)
Brainstorm Cell Therapeutics (BCLI) recorded Long-Term Investments of $20,000 in Q2 2015, up 33.3% from $15,000 a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Long-Term Investments (2010 - 2015) Analysis & Trends
Starting with Q4 2010, Brainstorm Cell Therapeutics' Long-Term Investments history includes 18 quarters.
- Annual Long-Term Investments has a four-year compound annual growth rate of -31.5% (FY2010 to FY2014).
- Across earlier years, Long-Term Investments came in at $22,000 in FY2013 (+29.4%), $17,000 in FY2012 (-86.5%), $126,000 in FY2011 (+38.5%) and $91,000 in FY2010.
- Quarterly Long-Term Investments has ranged from $13,000 in Q1 2014 to $273,000 in Q3 2013 over the past five years.
- On a year-over-year basis, Long-Term Investments rose in four of the last eight quarters, with an average decline of 14.1%.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 67.5% in Q3 2013, against a decline of 94.0% in Q1 2014 at the low end.
- Per Business Quant, the preceding three quarters came in at $19,000 (Q1 2015), $20,000 (Q4 2014) and $21,000 (Q3 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 20,000.00 |
| Mar 31, 2015 | 19,000.00 |
| Dec 31, 2014 | 20,000.00 |
| Sep 30, 2014 | 21,000.00 |
| Jun 30, 2014 | 15,000.00 |
| Mar 31, 2014 | 13,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Sep 30, 2013 | 273,000.00 |
| Jun 30, 2013 | 241,000.00 |
| Mar 31, 2013 | 218,000.00 |
| Dec 31, 2012 | 17,000.00 |
| Sep 30, 2012 | 163,000.00 |
| Jun 30, 2012 | 151,000.00 |
| Mar 31, 2012 | 146,000.00 |
| Dec 31, 2011 | 126,000.00 |
| Sep 30, 2011 | 107,000.00 |
| Jun 30, 2011 | 103,000.00 |
| Dec 31, 2010 | 91,000.00 |
API Access
Brainstorm Cell Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();